Stage 2 Capital — 2020 Investments
1 investments dated 2020 · listed companies and verified rows first · show all
DeepScribe builds an ambient AI documentation platform for oncology, including an AI medical scribe, pre-visit chart summaries, AI medical coding, and note customization.
AI & Machine LearningDigital HealthHealthtechSan Francisco, US
Matthew Ko(Executive Officer, Director)inAkilesh Dyanesh Bapu(Executive Officer, Director)Akilesh Bapu(Founder)inKairui Zeng(Executive Officer)
BoardMichael Berolzheimer(Director)in
Co-investorsBerkeley SkyDeck FundFoothill VenturesFour Acres CapitalIndex Ventures1984 Ventures Management, LlcBee Partners+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.